80_FR_10167 80 FR 10130 - Center for Scientific Review; Notice of Closed Meetings

80 FR 10130 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 37 (February 25, 2015)

Page Range10130-10131
FR Document2015-03778

Federal Register, Volume 80 Issue 37 (Wednesday, February 25, 2015) 
[Federal Register Volume 80, Number 37 (Wednesday, February 25, 2015)]
[Notices]
[Pages 10130-10131]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-03778]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Autoimmunity Transplantation Intolerance.
    Date: March 11, 2015.
    Time: 3:00 p.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Betty Hayden, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4206, MSC 7812, Bethesda, MD 20892, 301-435-
1223, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Topics in Drug Discovery and Mechanisms of Antimicrobial 
Resistance.
    Date: March 13, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Guangyong Ji, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435-
1146, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Skeletal Muscle related SBIR/STTR.
    Date: March 17, 2015.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Richard Ingraham, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD 
20892, 301-496-8551, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Program Project: Regulation of Cell Survival and Death 
Pathways by Fe-S Proteins.
    Date: March 19-20, 2015.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).

[[Page 10131]]

    Contact Person: William A. Greenberg, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4168, MSC 7806, Bethesda, MD 
20892, (301) 435-1726, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


    Dated: February 19, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-03778 Filed 2-24-15; 8:45 am]
BILLING CODE 4140-01-P

10130 Federal Register / Vol. 80, No. 37 / Wednesday, February 25, 2015 / Notices progressive multifocal cell division. 89Zr-oxine labeled cells The meetings will be closed to the leukoencephalopathy (PML), and can also be easily cross labeled (for public in accordance with the trichodysplasia spinulosa (TS). The example, optically or magnetically) for provisions set forth in sections methods could also be used to restore multi-modality imaging and analysis. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., polyomavirus-specific immunity in Labeled cell migration and kinetics can as amended. The grant applications and immunocompromised individuals. be analyzed and quantified in vivo over the discussions could disclose Potential Commercial Applications: a week, improving research strategies confidential trade secrets or commercial Immunotherapy for immunosuppressed and ability to develop and improve cell property such as patentable material, individuals with polyomavirus- therapies and diagnostics. and personal information concerning associated pathologies. Potential Commercial Applications: individuals associated with the grant Competitive Advantages: Methods Cell therapies and diagnostics. applications, the disclosure of which allow development of polyomavirus Competitive Advantages: Simple would constitute a clearly unwarranted antigen-specific T cells. preparation, broadly applicable cell invasion of personal privacy. Development Stage: label, high resolution imaging and Name of Committee: Center for Scientific • Early-stage monitoring over period of a week, low Review Special Emphasis Panel; Member • In vitro data available toxicity, easily combined with labeling Conflict: Autoimmunity Transplantation Inventors: John A. Barrett (NHLBI), technologies and cell therapies. Intolerance. Dhanalakshmi Chinnasamy (NHLBI), Development Stage: In vivo data Date: March 11, 2015. Pawel J. Muranski (NHLBI), Christopher available (animal). Time: 3:00 p.m. to 7:00 p.m. B. Buck (NCI) Inventors: Noriko Sato (NCI), Haitao Agenda: To review and evaluate grant Intellectual Property: HHS Reference Wu (NHLBI), Gary L. Griffiths (NCI), applications. No. E–166–2014/0—US Application No. Peter L. Choyke (NCI) Place: National Institutes of Health, 6701 62/075,726 filed November 5, 2014 Publications: Rockledge Drive, Bethesda, MD 20892, Related Technologies: 1. Sato N, et al. Generation and use of (Telephone Conference Call). • HHS Reference No. E–168–2011 long-lasting cell labeling agent for Contact Person: Betty Hayden, Ph.D., Scientific Review Officer, Center for • HHS Reference No. E–549–2013 positron emission tomography (PET) imaging. J Nucl Med. May 2014; 55 Scientific Review, National Institutes of Licensing Contact: Patrick McCue, Health, 6701 Rockledge Drive, Room 4206, Ph.D.; 301–435–5560; mccuepat@ (Supplement 1):273. MSC 7812, Bethesda, MD 20892, 301–435– od.nih.gov 2. Sato N, et al. 89Zr-oxine complex 1223, haydenb@csr.nih.gov. Collaborative Research Opportunity: positron emission tomography (PET) Name of Committee: Center for Scientific The National Heart, Lung, and Blood cell imaging for monitoring cell-based Review Special Emphasis Panel; Topics in Institute is seeking statements of therapies. Radiology, 2015, In press. Drug Discovery and Mechanisms of capability or interest from parties Intellectual Property: HHS Reference Antimicrobial Resistance. interested in collaborative research to No. E–080–2014/0—US Patent Date: March 13, 2015. further develop, evaluate or Application No. 61/973,706 filed April Time: 8:00 a.m. to 6:00 p.m. commercialize methods to generate T 1, 2014 Agenda: To review and evaluate grant cells responsive to multiple Licensing Contact: Edward (Tedd) applications polyomaviruses. For collaboration Fenn; 424–297–0336; Tedd.fenn@ Place: Residence Inn Bethesda, 7335 opportunities, please contact Dr. nih.gov Wisconsin Avenue, Bethesda, MD 20814. Vincent Kolesnitchenko at kolesniv@ Collaborative Research Opportunity: Contact Person: Guangyong Ji, Ph.D., The National Cancer Institute is seeking Scientific Review Officer, Center for nhlbi.nih.gov. Scientific Review, National Institutes of statements of capability or interest from 89Zr-Oxine Complex for In Vivo PET parties interested in collaborative Health, 6701 Rockledge Drive, Room 3211, Imaging of Labelled Cells and research to further develop, evaluate or MSC 7808, Bethesda, MD 20892, 301–435– 1146, jig@csr.nih.gov. Associated Methods commercialize cell labeling, cell tracking, cell trafficking, cell-based Name of Committee: Center for Scientific Description of Technology: This Review Special Emphasis Panel; Skeletal technology relates to a Zirconium-89 therapy, PET imaging. For collaboration Muscle related SBIR/STTR. (89Zr)-oxine complex for cell labeling, opportunities, please contact John D. Date: March 17, 2015. tracking of labeled cells by whole-body Hewes, Ph.D. at john.hewes@nih.gov or Time: 1:00 p.m. to 4:00 p.m. positron emission tomography/ 240–276–5515. Agenda: To review and evaluate grant computed tomography (PET/CT) Dated: February 18, 2015. applications. imaging, and associated methods. A Richard U. Rodriguez, Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, long half-life of 89Zr (78.4 hours), high Acting Director, Office of Technology (Telephone Conference Call). sensitivity of PET and absence of Transfer, National Institutes of Health. Contact Person: Richard Ingraham, Ph.D., background signal in the recipient [FR Doc. 2015–03779 Filed 2–24–15; 8:45 am] Scientific Review Officer, Center for enable tracking cells over a week using BILLING CODE 4140–01–P Scientific Review, National Institutes of low levels of labeling radioactivity, Health, 6701 Rockledge Drive, Room 4116, without causing cellular toxicity. The MSC 7814, Bethesda, MD 20892, 301–496– 89Zr-oxine complex is synthesized DEPARTMENT OF HEALTH AND 8551, ingrahamrh@mail.nih.gov. quickly by mixing components at room HUMAN SERVICES Name of Committee: Center for Scientific temperature and produces high yields. Review Special Emphasis Panel; Program asabaliauskas on DSK5VPTVN1PROD with NOTICES Cell labeling is achieved by a short, National Institutes of Health Project: Regulation of Cell Survival and room temperature incubation. The 89Zr- Death Pathways by Fe-S Proteins. Center for Scientific Review; Notice of Date: March 19–20, 2015. oxine complex is capable of labeling a Closed Meetings Time: 11:00 a.m. to 5:00 p.m. wide range of cell types of therapeutic Agenda: To review and evaluate grant or pathogenic relevance (natural, Pursuant to section 10(d) of the applications. disease, engineered cells), independent Federal Advisory Committee Act, as Place: National Institutes of Health, 6701 of factors such as cell cycle or receptor amended (5 U.S.C. App.), notice is Rockledge Drive, Bethesda, MD 20892, expression. The label is retained during hereby given of the following meetings. (Virtual Meeting). VerDate Sep<11>2014 18:05 Feb 24, 2015 Jkt 235001 PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 E:\FR\FM\25FEN1.SGM 25FEN1

Federal Register / Vol. 80, No. 37 / Wednesday, February 25, 2015 / Notices 10131 Contact Person: William A. Greenberg, in this notice, Policy Letter 01–14 On February 7, 2014, the Coast Guard Ph.D., Scientific Review Officer, Center for became Policy Letter 01–15 and Policy published two draft policy letters (CG– Scientific Review, National Institutes of Letter 02–14 became Policy Letter 02– OES 01–14 and CG–OES 02–14), Health, 6701 Rockledge Drive, Room 4168, 15. requesting comments, that MSC 7806, Bethesda, MD 20892, (301) 435– 1726, greenbergwa@csr.nih.gov. FOR FURTHER INFORMATION CONTACT: If recommended the transfer procedures you have questions on this notice, call and other operating guidelines for (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; or email Ken Smith, Vessel and Facility vessels and waterfront facilities 93.333, Clinical Research, 93.306, 93.333, Operating Standards Division (CG– providing LNG to vessels for use as fuel 93.337, 93.393–93.396, 93.837–93.844, OES–2), U.S. Coast Guard; telephone and for vessels operating in U.S. waters 93.846–93.878, 93.892, 93.893, National 202–372–1413, email Ken.A.Smith@ that will be fueled with natural gas that Institutes of Health, HHS) uscg.mil. If you have questions on will be stored onboard as LNG. The viewing or submitting material to the Coast Guard has revised these policy Dated: February 19, 2015. docket, call Cheryl Collins, Program letters based on comments received and Carolyn Baum, now makes the final policy letters Manager, Docket Operations, telephone Program Analyst, Office of Federal Advisory available to the public. Committee Policy. 202–366–9826. The policy letters and voluntary SUPPLEMENTARY INFORMATION: [FR Doc. 2015–03778 Filed 2–24–15; 8:45 am] guidance do not apply to vessels Viewing material in the docket: To BILLING CODE 4140–01–P regulated as LNG carriers that utilize view the policy letters and related their boil-off gas as fuel. They also do material, go to http:// not provide guidance on vessel design www.regulations.gov, type the docket DEPARTMENT OF HOMELAND criteria for natural gas fuel systems or number (USCG–2013–1084) in the SECURITY design of vessels providing LNG for use ‘‘SEARCH’’ box and click ‘‘SEARCH.’’ as fuel. If you have questions about the Click on ‘‘Open Docket Folder’’ on the Coast Guard design of these systems, please contact line associated with this notice. If you the Coast Guard’s Office of Design and [Docket No. USCG–2013–1084] do not have access to the Internet, you Engineering Standards (CG–ENG, may view the docket online by visiting Policy Letters: Guidance for the Use of formerly CG–521). See FOR FURTHER the Docket Management facility in Liquefied Natural Gas as a Marine Fuel INFORMATION CONTACT section for contact Room W12–140 on the ground floor of information. AGENCY: Coast Guard, DHS. the Department of Transportation West Building, 1200 New Jersey Avenue SE., Discussion ACTION: Notice of availability. Washington, DC 20590, between 9 a.m. The Coast Guard received 27 letters SUMMARY: On February 7, 2014, the and 5 p.m., Monday through Friday, from the public containing a combined Coast Guard announced the availability, except Federal holidays. We have an total of 185 individual comments which in the docket, of two draft policy letters agreement with the Department of are discussed below. We discuss more for which it sought public comment. Transportation to use the Docket fully the changes we made to the policy This notice announces the availability Management Facility. letters in response to comments. of the finalized Coast Guard policy Privacy Act: Anyone can search the All letters received were generally letters, including explanations of electronic form of comments received supportive of the Coast Guard’s effort to changes made to the policy letters and into any of our dockets by the name of provide guidance on the use and enclosures based on the public the individual submitting the comment transfer of LNG as a marine fuel and the comments received. The first policy (or signing the comment, if submitted Coast Guard appreciates this important letter provides voluntary guidance for on behalf of an association, business, feedback. liquefied natural gas (LNG) fuel transfer labor union, etc.). You may review a We also received various comments operations on vessels using natural gas Privacy Act, system of records notice recommending changes that cannot be as fuel in U.S. waters, and training of regarding our public dockets in the made in a policy document because the personnel on those vessels. It January 17, 2008, issue of the Federal Coast Guard would need to undergo recommends transfer and personnel Register (73 FR 3316). rulemaking to make these recommended training measures that we believe will Background and Purpose changes enforceable. For example, one achieve a level of safety that is at least submitter suggested that we provide The shipping industry is exploring equivalent to that provided for specific details concerning the conversion from oil-based fuel to traditional fueled vessels. It applies to cleaner burning natural gas, because the information that risk assessments vessels equipped to receive LNG for use use of natural gas as fuel would should contain. Another submitter as fuel, but not to vessels regulated as substantially reduce carbon emissions, suggested that we provide common LNG carriers that utilize boil-off gas as sulfur emissions, and nitrogen oxide checklists for industry to follow when fuel. The second policy letter discusses emissions. This natural gas fuel would conducting bunkering operations. The voluntary guidance and existing be stored on and transferred to vessels Coast Guard will consider these regulations applicable to vessels and in the form of liquefied natural gas comments and determine whether any waterfront facilities conducting LNG (LNG). Existing regulations cover further action is necessary. marine fuel transfer (bunkering) design, equipment, operations, and Additionally, the Coast Guard received operations. The second policy letter comments on matters unrelated to the asabaliauskas on DSK5VPTVN1PROD with NOTICES training of personnel on vessels that provides voluntary guidance on safety, carry LNG as cargo and at waterfront two policy letters discussed in this security, and risk assessment measures facilities that handle LNG in bulk. They notice. Those comments have been we believe will enhance safe LNG also cover conventional oil fuel transfer reviewed but did not effect any changes bunkering operations. Both policy operations, but do not address LNG to these policy letters. Examples of some letters are available on the public transferred as fuel.1 of the comments we received pertaining docket. They have been updated to to design were related to venting reflect publication numbers of the 1 33 CFR parts 127, 155 and 156; 46 CFR parts 10– arrangements, LNG tank design, and gas current year. Accordingly, as discussed 15, 30–39, and 154. detection. VerDate Sep<11>2014 18:05 Feb 24, 2015 Jkt 235001 PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 E:\FR\FM\25FEN1.SGM 25FEN1


Document Created: 2015-12-18 13:08:46
Document Modified: 2015-12-18 13:08:46
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 11, 2015.
FR Citation80 FR 10130 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR